USANA Health Sciences Balance Sheet Health
Financial Health criteria checks 5/6
USANA Health Sciences has a total shareholder equity of $500.0M and total debt of $1.3M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are $629.3M and $129.3M respectively. USANA Health Sciences's EBIT is $90.9M making its interest coverage ratio -8.9. It has cash and short-term investments of $328.3M.
Key information
0.3%
Debt to equity ratio
US$1.32m
Debt
Interest coverage ratio | -8.9x |
Cash | US$328.34m |
Equity | US$499.99m |
Total liabilities | US$129.29m |
Total assets | US$629.28m |
Recent financial health updates
Recent updates
USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
May 01USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27USANA Earnings Preview: From China's Challenge To India's Promise
Jul 21USANA Health Sciences says Brown will transition to CEO in July 2023
Feb 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Feb 02USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates
Oct 25Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return
Oct 18Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?
Jul 22Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled
Jul 07Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?
Jun 14Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?
May 31USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside
Apr 28Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future
Mar 05USANA: 15x P/E, 14% Net Cash, Stock Repurchases
Feb 17A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)
Jan 24At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?
Jan 11Financial Position Analysis
Short Term Liabilities: USNA's short term assets ($421.1M) exceed its short term liabilities ($112.6M).
Long Term Liabilities: USNA's short term assets ($421.1M) exceed its long term liabilities ($16.7M).
Debt to Equity History and Analysis
Debt Level: USNA has more cash than its total debt.
Reducing Debt: USNA's debt to equity ratio has increased from 0% to 0.3% over the past 5 years.
Debt Coverage: USNA's debt is well covered by operating cash flow (5719%).
Interest Coverage: USNA earns more interest than it pays, so coverage of interest payments is not a concern.